CEE COURSE: Transfusion Related Respiratory Complications: An Update on TRALI, TACO & TAD

European and U.S. hemovigilance programs have provided guidelines defining the various transfusion-related complications. The focus of this course will be distinctions and similarities between the primary transfusion related respiratory complications and the hemovigilance definitions of TRALI, TACO and TAD.

TARGET AUDIENCE: This activity has been designed for general, specialty, and subspecialty physicians who prescribe blood products, care for blood donors or have related interests. There are no participant prerequisites for this activity.

Enter Course

LEARNING OBJECTIVES
At the conclusion of this course, participants should be able to:

  1. Describe the difference between cardiogenic and non-cardiogenic edema..
  2. List criteria for TRALI, TACO and TAD as defined by the National Healthcare Safety Network (NHSN) and ISBT/IHN/AABB.
  3. Identify clinical and aboratory variables helpful in distinguishing transfusion related respiratory complications.
  4. Identify predisposing risk factors for these events.

LEARNING TASKS
To receive CME credit for this course, participants must:

  1. Acknowledge your review of the activity prerequisites, objectives, disclosures, methods of physician participation and statements.
  2. Review the presentation " Transfusion Related Respiratory Complications: An Update on TRALI, TACO & TAD" or read the PowerPoint slides and accompanying notes available as a printable Adobe ReaderĀ® file.
  3. Take the online Post-Test.
  4. Complete the online Course Evaluation.
  5. Print the certificate awarding awarding 1.0 AMA PRA Category 1 credit(s)TM through the SUCCESSTM program.

FACULTY
Marla Troughton, MD
Medical Director, American Red Cross Blood Services
Alabama and Central Gulf Coast Region
Birmingham, AL

ACTIVITY PLANNER
Liz Marcus
Director, Hospital Sales and Marketing
Biomedical Headquarters American Red Cross
Washington DC

DISCLOSURES
The faculty has indicated that he has the following relevant disclosure: For research on a rapid infusion device three companies, Belmont Instrument Corp, Intermountain Foundation, and Haemonetics as well as the US Army provided financial support. No commercial support was received for this activity.

DISCLAIMER
The opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of the American Red Cross Biomedical Services. Information herein is presented for educational purposes only.

ACCREDITATION STATEMENT
The American Red Cross Biomedical Services (ARCBS) is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

DESIGNATION STATEMENT
The American Red Cross Biomedical Services designates this educational activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)TM ; physicians should only claim credit commensurate with the extent of their participation in the activity.

PASSING REQUIREMENTS
If you correctly answer 75% or more of the post-test items you may claim credit.

DISCLOSURE STATEMENT
All faculty participating in ARCBS continuing medical education programs are expected to disclose to learners whether they do or do not have any real or apparent conflict(s) of interest or other relationships related to the content of their presentation(s); faculty are also expected to disclose off-label and/or investigational uses of products under discussion.


RELEASE DATE: 09/03/2019

CME CREDITS: 1.0 AMA PRA Category 1 Credit(s)TM

EXPIRATION DATE: 09/03/2022

ESTIMATED TIME TO COMPLETE ACTIVITY:
1.0 hour
Last modified: Tuesday, September 3, 2019, 03:03 PM